Background: Internalizing problems are the most prevalent mental health problems in adolescents. Transdiagnostic programs are promising manners to treat multiple problems within the same protocol, however, there is limited research regarding the efficacy of such programs delivered as universal prevention programs in school settings. Therefore, the present study aims to investigate the efficacy of a video-based transdiagnostic rational emotive behavioral therapy (REBT) universal prevention program, for internalizing problems. The second objective of the present paper will be to investigate the subsequent mechanisms of change, namely maladaptive cognitions.

Methods: A two-arm parallel randomized controlled trial will be conducted, with two groups: a video-based transdiagnostic REBT universal prevention program and a wait list control. Power analysis indicated that the study will involve 338 participants. Adolescents with ages between 12 and 17 years old, from several middle schools and high schools, will be invited to participate. Assessments will be conducted at four time points: baseline (T), post-intervention (T), 3 months follow-up (T) and 12 months follow-up (T). Intent-to-treat analysis will be used in order to investigate significant differences between the two groups in both primary and secondary outcomes.

Discussion: This is the first randomized controlled trial that aims to investigate the efficacy and mechanisms of change of a video-based transdiagnostic REBT universal prevention program, delivered in a school context. The present study has important implications for developing efficient prevention programs, interactive, that will aim to target within the same protocol both anxiety and depressive symptoms.

Trial Registration: ClinicalTrials.gov: NCT02756507 . Registered on 25 April 2016.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899379PMC
http://dx.doi.org/10.1186/s12888-018-1684-0DOI Listing

Publication Analysis

Top Keywords

universal prevention
20
video-based transdiagnostic
16
rebt universal
16
prevention program
16
transdiagnostic rebt
12
internalizing problems
12
randomized controlled
12
controlled trial
12
program internalizing
8
problems adolescents
8

Similar Publications

Endogenous reward (intrinsic reward at will) is a that is by steps toward any goals which are challenging and/or uncommon enough to prevent its debasement by inflation. A "theory of mental computational processes" should propose what properties let goals grow from appetites for endogenous rewards. Endogenous reward may be the universal selective factor in all modifiable mental processes.

View Article and Find Full Text PDF

Introduction: Rabies monoclonal antibody (mAb) is a life-saving immune-biological for postexposure prophylaxis (PEP) in all Category III animal exposures. A novel cocktail of mAbs derived using recombinant DNA technology is presently available for usage. The WHO recommends monitoring the clinical use and outcomes of mAb products.

View Article and Find Full Text PDF

Background: Access to essential healthcare services is pertinent to the achievement of universal health coverage in any nation. The COVID-19 lockdown was used to mitigate the spread of the pandemic. Consequently, there was a reduction in the Utilisation of Basic Healthcare Services (UBHS) in diverse dimensions.

View Article and Find Full Text PDF

Predicting and optimising outcome for biliary atresia.

Semin Pediatr Surg

January 2025

Dept of Paediatric Surgery, Kings College Hospital, London SE59RS, England, United Kingdom. Electronic address:

Biliary atresia (BA) remains a disease of significant morbidity and mortality world-wide. Early and accurate diagnosis facilitates early intervention and improves outcomes. The gold standard in diagnosing BA is a liver biopsy followed by cholangiography, usually performed intra-operatively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!